Alkindi Sprinkle (hydrocortisone) NDC 71863-111

NDC codes

FDA NDC Directory

Product NDC (as listed)71863-111Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71863-0111Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71863-111-50	71863011150	1 BOTTLE, PLASTIC in 1 CARTON (71863-111-50) / 50 GRANULE in 1 BOTTLE, PLASTICMarketed from Sep 29, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Alkindi SprinkleSuffix: Sprinkle
Generic name (nonproprietary): hydrocortisone
Active ingredients: Hydrocortisone — 2 mg/1
Dosage form: Granule
Route: Oral
Labeler: Eton Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 213876
Marketing start: Sep 29, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 71863-111_4ffdccff-95d3-7c88-e063-6394a90a1c9fSPL ID 4ffdccff-95d3-7c88-e063-6394a90a1c9fSPL set ID 26c13a5f-7119-4c6a-bf10-fda4e07d7682RxCUI 2399644, 2399650, 2399652, 2399654, 2399656, 2399658, 2399659, 2399661UNII WI4X0X7BPJ
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471863011150 followed by a unit qualifier and the quantity

Package 71863-0111-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 21, 2026.

Indications (excerpt from the label)

ALKINDI SPRINKLE is indicated as replacement therapy in pediatric patients with adrenocortical insufficiency. ALKINDI SPRINKLE is a corticosteroid indicated as replacement therapy in pediatric patients with adrenocortical insufficiency. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 213876

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 213876
Product	Strength	Form · route	Labeler	Product NDC
Alkindi Sprinklehydrocortisone	Hydrocortisone 1 mg/1	GranuleOral	Eton Pharmaceuticals, Inc.	71863-110
Alkindi Sprinklehydrocortisone	Hydrocortisone .5 mg/1	GranuleOral	Eton Pharmaceuticals, Inc.	71863-109
Alkindi Sprinklehydrocortisone	Hydrocortisone 5 mg/1	GranuleOral	Eton Pharmaceuticals, Inc.	71863-112